Contact

All Stories

  1. Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the BCR-ABL Gene: An Hierarchical Biochemoinformatics Analysis

    Article • Pharmaceuticals, November 2024, MDPI AG

    Professor Joaquin M Campos

  2. Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats

    Article • Drug Design Development and Therapy, April 2024, Taylor & Francis

    Professor Joaquin M Campos

  3. Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach

    Article • Pharmaceuticals, November 2023, MDPI AG

    Professor Joaquin M Campos

  4. Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions

    Article • Pharmaceuticals, November 2023, MDPI AG

    Professor Joaquin M Campos

  5. Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains

    Article • Pharmaceuticals, October 2023, MDPI AG

    Professor Joaquin M Campos

  6. Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Professor Joaquin M Campos

  7. Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

    Article • Molecules, January 2023, MDPI AG

    Professor Joaquin M Campos

  8. Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies

    Article • Pharmaceuticals, January 2023, MDPI AG

    Professor Joaquin M Campos

  9. Hierarchical Virtual Screening and Binding Free Energy Prediction of Potential Modulators of Aedes Aegypti Odorant-Binding Protein 1

    Article • Molecules, October 2022, MDPI AG

    Professor Joaquin M Campos

  10. Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Professor Joaquin M Campos

  11. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review

    Article • Current Medicinal Chemistry, May 2022, Bentham Science Publishers

    Professor Joaquin M Campos, Mark Kimani

  12. Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Professor Joaquin M Campos

  13. An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists

    Article • Current Medicinal Chemistry, September 2021, Bentham Science Publishers

    Professor Joaquin M Campos

  14. Development of Bozepinib-Loaded Nanocapsules for Nose-To-Brain Delivery: Preclinical Evaluation in Glioblastoma

    Article • Nanomedicine, September 2021, Taylor & Francis

    Professor Joaquin M Campos

  15. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases

    Article • Pharmaceutics, May 2021, MDPI AG

    Professor Joaquin M Campos

  16. Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2021, Taylor & Francis

    Professor Joaquin M Campos

  17. Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches

    Article • Molecules, September 2020, MDPI AG

    Professor Joaquin M Campos

  18. Alkylated Sesamol Derivatives as Potent Antioxidants

    Article • Molecules, July 2020, MDPI AG

    Professor Joaquin M Campos

  19. Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs

    Article • Journal of Biomolecular Structure and Dynamics, May 2020, Taylor & Francis

    Professor Joaquin M Campos

  20. Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches

    Article • Molecules, March 2020, MDPI AG

    Professor Joaquin M Campos

  21. Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening

    Article • Molecules, August 2019, MDPI AG

    Professor Joaquin M Campos

  22. Antioxidant effect of flavonoids present in Euterpe oleracea Martius and neurodegenerative diseases: A literature review

    Article • Central Nervous System Agents in Medicinal Chemistry, May 2019, Bentham Science Publishers

    Professor Joaquin M Campos

  23. Hierarchical Virtual Screening of Potential Insectides Inhibitors of Acetylcholinesterase and Juvenile Hormone from Temephos

    Article • Pharmaceuticals, April 2019, MDPI AG

    Professor Joaquin M Campos

  24. In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity

    Article • Molecules, April 2019, MDPI AG

    Professor Joaquin M Campos

  25. In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations

    Article • Pharmaceuticals, March 2019, MDPI AG

    Professor Joaquin M Campos

  26. Identification of Potential Inhibitors from Pyriproxyfen with Insecticidal Activity by Virtual Screening

    Article • Pharmaceuticals, January 2019, MDPI AG

    Professor Joaquin M Campos

  27. Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism

    Article • Molecules, January 2019, MDPI AG

    Professor Joaquin M Campos

  28. An In Silico Study of the Antioxidant Ability for Two Caffeine Analogs Using Molecular Docking and Quantum Chemical Methods

    Article • Molecules, October 2018, MDPI AG

    Professor Joaquin M Campos

  29. Development of Biotransamination Reactions towards the 3,4-Dihydro-2H-1,5-benzoxathiepin-3-amine Enantiomers

    Article • Catalysts, October 2018, MDPI AG

    Professor Joaquin M Campos

  30. An Antioxidant Potential, Quantum-Chemical and Molecular Docking Study of the Major Chemical Constituents Present in the Leaves of Curatella americana Linn

    Article • Pharmaceuticals, July 2018, MDPI AG

    Professor Joaquin M Campos

  31. In Silico Evaluation of the Antioxidant Potential of Two Caffeine Analogs with Recognized Epithelial Anticancer Potential

    Article • May 2018, MDPI AG

    Professor Joaquin M Campos

  32. Reverse Induced Fit-Driven MAS-Downstream Transduction: Looking for Metabotropic Agonists

    Article • Current Medicinal Chemistry, December 2017, Bentham Science Publishers

    Professor Joaquin M Campos

  33. Inhibitors of Cancer Stem Cells

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2016, Bentham Science Publishers

    Professor Joaquin M Campos

  34. Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy

    Article • Current Medicinal Chemistry, March 2015, Bentham Science Publishers

    Professor Joaquin M Campos

  35. p-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o-(purine-methyl)anilines as novel antitumour agents

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Joaquin M Campos

  36. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes

    Article • European Journal of Medicinal Chemistry, January 2015, Elsevier

    Professor Joaquin M Campos

  37. Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells

    Article • Molecular Cancer Therapeutics, January 2015, American Association for Cancer Research (AACR)

    Professor Joaquin M Campos

  38. 4-Amino Bis-Pyridinium Derivatives as Novel Antileishmanial Agents

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    Professor Joaquin M Campos

  39. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines

    Article • European Journal of Medicinal Chemistry, April 2014, Elsevier

    Professor Joaquin M Campos

  40. Stereospecific alkylation of substituted adenines by the Mitsunobu coupling reaction under microwave-assisted conditions

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Professor Joaquin M Campos

  41. Enantiospecific Synthesis of Heterocycles Linked to Purines: Different Apoptosis Modulation of Enantiomers in Breast Cancer Cells

    Article • Current Medicinal Chemistry, November 2013, Bentham Science Publishers

    Professor Joaquin M Campos

  42. Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence

    Article • Drug Design Development and Therapy, October 2013, Taylor & Francis

    Professor Joaquin M Campos

  43. Chromatographic Enantioresolution of Six Purine Derivatives Endowed with Anti-Human Breast Cancer Activity

    Article • Chromatographia, January 2013, Springer Science + Business Media

    Professor Joaquin M Campos

  44. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis

    Article • European Journal of Medicinal Chemistry, April 2012, Elsevier

    Professor Joaquin M Campos

  45. Novel 4‐Amino Bis‐pyridinium and Bis‐quinolinium Derivatives as Choline Kinase Inhibitors with Antiproliferative Activity against the Human Breast Cancer SKBR‐3 Cell Line

    Article • ChemMedChem, January 2012, Wiley

    Professor Joaquin M Campos

  46. Synthesis, unambiguous chemical characterization, and reactivity of 2,3,4,5-tetrahydro-1,5-benzoxazepines-3-ol

    Article • RSC Advances, January 2012, Royal Society of Chemistry

    Professor Joaquin M Campos

  47. Two tautomeric polymorphs of 2,6-dichloropurine

    Article • Acta Crystallographica Section C Crystal Structure Communications, November 2011, International Union of Crystallography

    Professor Joaquin M Campos

  48. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine

    Article • European Journal of Medicinal Chemistry, September 2011, Elsevier

    Professor Joaquin M Campos

  49. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines

    Article • European Journal of Medicinal Chemistry, September 2011, Elsevier

    Professor Joaquin M Campos

  50. The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells

    Article • PLOS One, August 2011, PLOS

    Professor Joaquin M Campos

  51. Synthesis and Anticancer Activity of the (R,S)‐Benzofused 1,5‐Oxathiepine Moiety Tethered to Purines through Alkylidenoxy Linkers

    Article • ChemMedChem, July 2011, Wiley

    Professor Joaquin M Campos

  52. Homodimeric Bis-Quaternary Heterocyclic Ammonium Salts as Potent Acetyl- and Butyrylcholinesterase Inhibitors: A Systematic Investigation of the Influence of Linker and Cationic Heads over Affinity and Selectivity

    Article • Journal of Medicinal Chemistry, April 2011, American Chemical Society (ACS)

    Professor Joaquin M Campos

  53. Syntheses of 2,3-Dihydro-1,4-Benzodioxins and Bioisosteres as Structural Motifs for Biologically Active Compounds

    Article • Current Organic Chemistry, March 2011, Bentham Science Publishers

    Professor Joaquin M Campos

  54. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine

    Article • European Journal of Medicinal Chemistry, January 2011, Elsevier

    Professor LUISA CARLOTA LOPEZ-CARA, Professor Joaquin M Campos

  55. Synthesis of Purine Derivatives as Scaffolds for a Diversity of Biological Activities

    Article • Current Organic Chemistry, December 2010, Bentham Science Publishers

    Professor Joaquin M Campos

  56. Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines

    Article • Current Medicinal Chemistry, October 2008, Bentham Science Publishers

    Professor Joaquin M Campos

  57. From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: the shift from differentiating anticancer agents to apoptotic inducers

    Article • Expert Opinion on Drug Discovery, September 2008, Informa Healthcare

    Professor Joaquin M Campos

  58. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines

    Article • European Journal of Medicinal Chemistry, August 2008, Elsevier

    Professor Joaquin M Campos

  59. Bis-Quinolinium Cyclophanes: Highly Potent and Selective Non-Peptidic Blockers of the Apamin-Sensitive Ca2+-Activated K+ Channel

    Article • Current Medicinal Chemistry, June 2008, Bentham Science Publishers

    Professor Joaquin M Campos

  60. Thermal N-9 → N-7 Isomerization of (6-Substituted)-9-(2,3-Dihydro-5H-1,4-Benzodioxepin-3-yl)-9H-Purines in Solution: Mechanistic Aspects

    Article • Mini-Reviews in Organic Chemistry, May 2008, Bentham Science Publishers

    Professor Joaquin M Campos

  61. Inhibition of immune complex-mediated neutrophil oxidative metabolism: A pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures

    Article • European Journal of Medicinal Chemistry, May 2008, Elsevier

    Professor Joaquin M Campos

  62. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies

    Article • Bioorganic & Medicinal Chemistry Letters, February 2008, Elsevier

    Professor Joaquin M Campos

  63. Latest advances on regiospecific microwave-assisted synthesis of novel purine derivatives as antitumor agents

    Article • Expert Opinion on Therapeutic Patents, February 2008, Informa Healthcare

    Professor Joaquin M Campos

  64. Synthesis and Anticancer Activity of (R,S)‐9‐(2,3‐Dihydro‐1,4‐Benzoxathiin‐3‐ylmethyl)‐9H‐Purines

    Article • ChemMedChem, January 2008, Wiley

    Professor Joaquin M Campos

  65. QSAR as a Tool for the Development of Potent Antiproliferative Agents by Inhibition of Choline Kinase

    Article • Current Computer - Aided Drug Design, December 2007, Bentham Science Publishers

    Professor Joaquin M Campos

  66. Antiproliferative Activity, Cell‐Cycle Dysregulation, and Cellular Differentiation: Salicyl‐ and Catechol‐Derived Acyclic 5‐Fluorouracil O,N‐Acetals against Breast Cancer Cells

    Article • ChemMedChem, November 2007, Wiley

    Professor Joaquin M Campos

  67. Corrigendum to “Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom”

    Article • Tetrahedron, September 2007, Elsevier

    Professor Joaquin M Campos

  68. Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom

    Article • Tetrahedron, June 2007, Elsevier

    Professor Joaquin M Campos

  69. (2,3-Dihydro-1,4-benzodioxin-2-yl)methanol

    Article • Acta Crystallographica Section E Structure Reports Online, May 2007, International Union of Crystallography

    Professor Joaquin M Campos

  70. 5-Fluorouracil Derivatives Induce Differentiation Mediated by Tubulin and HLA Class I Modulation

    Article • Medicinal Chemistry, May 2007, Bentham Science Publishers

    Professor Joaquin M Campos

  71. Design, Syntheses, Biological Evaluation, and Docking Studies of 2-Substituted 5-Methylsulfonyl-1-Phenyl-1H-Indoles: Potent and Selective in vitro Cyclooxygenase-2 Inhibitors

    Article • ChemMedChem, January 2007, Wiley

    Dr Juan J Diaz-Mochon, Professor Joaquin M Campos

  72. 6′-Chloro-7- or 9-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-7H- or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs

    Article • Tetrahedron, January 2007, Elsevier

    Professor Joaquin M Campos

  73. 1H and 13C NMR studies of 2‐functionalized 5‐(methylsulfonyl)‐1‐phenyl‐1H‐indoles

    Article • Magnetic Resonance in Chemistry, December 2006, Wiley

    Professor Joaquin M Campos

  74. Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines

    Article • Tetrahedron, December 2006, Elsevier

    Professor Joaquin M Campos

  75. A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells

    Article • Breast Cancer Research and Treatment, November 2006, Springer Science + Business Media

    Professor Joaquin M Campos

  76. Insight into the Inhibition of Human Choline Kinase: Homology Modeling and Molecular Dynamics Simulations

    Article • ChemMedChem, October 2006, Wiley

    Professor Joaquin M Campos

  77. (Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs

    Article • Current Medicinal Chemistry, May 2006, Bentham Science Publishers

    Professor Joaquin M Campos

  78. Study of the Factors that Control the Ratio of the Products between 5-Fluorouracil, Uracil, and Tetrahydrobenzoxazepine O,O-Acetals Bearing Electron-Withdrawing Groups on the Nitrogen Atom

    Article • The Journal of Organic Chemistry, January 2006, American Chemical Society (ACS)

    Professor Joaquin M Campos

  79. Synthesis of novel 1-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-uracil and -thymine, and their corresponding S-oxidized derivatives

    Article • Tetrahedron, October 2005, Elsevier

    Professor Joaquin M Campos

  80. Synthesis and NMR Studies on a C3-Symmetrical Triquinolina Triscationic Bicyclophane

    Article • The Journal of Organic Chemistry, June 2005, American Chemical Society (ACS)

    Professor Joaquin M Campos

  81. New Medium Oxacyclic O,N-Acetals and Related Open Analogues: Biological Activities

    Article • Current Medicinal Chemistry, June 2005, Bentham Science Publishers

    Professor Joaquin M Campos

  82. Symmetrical Bis-Quinolinium Compounds:  New Human Choline Kinase Inhibitors with Antiproliferative Activity against the HT-29 Cell Line

    Article • Journal of Medicinal Chemistry, April 2005, American Chemical Society (ACS)

    Professor Joaquin M Campos

  83. Towards a model for the inhibition of choline kinase by a new type of inhibitor

    Article • European Journal of Medicinal Chemistry, March 2005, Elsevier

    Professor Joaquin M Campos

  84. Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation

    Article • Il Farmaco, February 2005, Elsevier

    Professor Joaquin M Campos

  85. 1H and13C spectral assignment of symmetrical bis[(4-aminosubstituted)quinolinium] derivatives

    Article • Magnetic Resonance in Chemistry, January 2005, Wiley

    Professor Joaquin M Campos

  86. Substituent effects on the reaction mode between 2-hydroxybenzyl alcohol derivatives and MEM chloride: synthesis and mechanistic aspects of seven- and ten-membered benzo-fused O,O-acetals

    Article • Tetrahedron, December 2004, Elsevier

    Professor Joaquin M Campos

  87. Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells

    Article • Tetrahedron, December 2004, Elsevier

    Professor Joaquin M Campos

  88. Growth inhibition, G1-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives

    Article • Investigational New Drugs, November 2004, Springer Science + Business Media

    Professor Joaquin M Campos

  89. Influence of the Linker in Bispyridium Compounds on the Inhibition of Human Choline Kinase

    Article • Journal of Medicinal Chemistry, September 2004, American Chemical Society (ACS)

    Professor Joaquin M Campos

  90. Synthesis, Biological Activity, and Quantitative Structure−Activity Relationship Study of Azanaphthalimide and Arylnaphthalimide Derivatives

    Article • Journal of Medicinal Chemistry, March 2004, American Chemical Society (ACS)

    Professor Joaquin M Campos

  91. Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells

    Article • Oncogene, December 2003, Springer Science + Business Media

    Professor Joaquin M Campos

  92. Conformational Dynamics of a Bispyridinium Cyclophane

    Article • The Journal of Organic Chemistry, October 2003, American Chemical Society (ACS)

    Professor Joaquin M Campos

  93. Neighbouring-group participation as the key step in the reactivity of acyclic and cyclic salicyl-derived O,O-acetals with 5-fluorouracil. Antiproliferative activity, cell cycle dysregulation and apoptotic induction of new O,N-acetals against breast can...

    Article • Tetrahedron, September 2003, Elsevier

    Professor Joaquin M Campos

  94. QSAR-Derived Choline Kinase Inhibitors: How Rational can Antiproliferative Drug Design Be?

    Article • Current Medicinal Chemistry, July 2003, Bentham Science Publishers

    Professor Joaquin M Campos

  95. Medium benzene-fused oxacycles with the 5-fluorouracil moiety: synthesis, antiproliferative activities and apoptosis induction in breast cancer cells

    Article • Tetrahedron, July 2003, Elsevier

    Professor Joaquin M Campos

  96. Bispyridinium Cyclophanes:  Novel Templates for Human Choline Kinase Inhibitors

    Article • Journal of Medicinal Chemistry, June 2003, American Chemical Society (ACS)

    Professor Joaquin M Campos

  97. Synthesis and spectral study of a novel distamycin conjugate

    Article • Magnetic Resonance in Chemistry, May 2003, Wiley

    Professor Joaquin M Campos

  98. Choline kinase inhibitory effect and antiproliferative activity of new 1,1′,1″-(benzene-1,3,5-triylmethylene)tris?4-[(disubstituted)amino]pyridinium? tribromides

    Article • European Journal of Medicinal Chemistry, January 2003, Elsevier

    Professor Joaquin M Campos

  99. Quantitative structure–activity relationships for a series of symmetrical bisquaternary anticancer compounds

    Article • Bioorganic & Medicinal Chemistry, July 2002, Elsevier

    Professor Joaquin M Campos

  100. 1H and13C chemical shifts for bis(benzopyridinium) dibromides with semirigid aromatic linkers

    Article • Magnetic Resonance in Chemistry, June 2002, Wiley

    Dr Juan J Diaz-Mochon, Professor Joaquin M Campos

  101. Identification of Novel Cyclooxygenase-2 Selective Inhibitors Using Pharmacophore Models

    Article • Journal of Medicinal Chemistry, February 2002, American Chemical Society (ACS)

    Professor Joaquin M Campos

  102. cis- and trans-1-[3-(Hydroxymethyl)-1,4-dioxepan-5-yl]pyrimidines: a new nucleoside prototype with a seven-membered moiety

    Article • Tetrahedron, April 2001, Elsevier

    Professor Joaquin M Campos

  103. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase

    Article • European Journal of Medicinal Chemistry, March 2001, Elsevier

    Professor Joaquin M Campos

  104. From a Classic Approach in Cancer Chemotherapy Towards Differentiation Therapy: Acyclic and Cyclic Seven-Membered 5-Fluorouracil O,N-Acetals

    Article • Current Pharmaceutical Design, December 2000, Bentham Science Publishers

    Professor Joaquin M Campos

  105. QSAR of 1,1′-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design

    Article • Bioorganic & Medicinal Chemistry Letters, April 2000, Elsevier

    Professor Joaquin M Campos

  106. Synthesis, Molecular Modeling, and Pharmacological Testing of Bis-Quinolinium Cyclophanes:  Potent, Non-Peptidic Blockers of the Apamin-Sensitive Ca2+-Activated K+Channel

    Article • Journal of Medicinal Chemistry, December 1999, American Chemical Society (ACS)

    Professor Joaquin M Campos

  107. GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

    Article • British Journal of Cancer, January 1999, Springer Science + Business Media

    Professor Joaquin M Campos

  108. Synthesis of novel 5-fluorouracil derivatives with 1,4-oxaheteroepane moieties

    Article • Tetrahedron, October 1998, Elsevier

    Professor Joaquin M Campos

  109. Bis-Quinolinium Cyclophanes:  6,10-Diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non-Peptidic Blocker of the Apamin-Sensitive Ca2+-Activated K+ Channel

    Article • Journal of Medicinal Chemistry, January 1998, American Chemical Society (ACS)

    Professor Joaquin M Campos

  110. Choline kinase inhibitors as a novel approach for antiproliferative drug design

    Article • Oncogene, November 1997, Springer Science + Business Media

    Professor Joaquin M Campos

  111. Chemical modifications on the acyclic moiety of 3-(2-hydroxyethoxy)-1-alkoxypropyl nucleobases. 2. Differentiation and growth inhibition in rhabdomyosarcoma cells after exposure to a novel 5-fluorouracil acyclonucleoside

    Article • Tetrahedron, May 1997, Elsevier

    Professor Joaquin M Campos

  112. A New Systematization of the Conformational Behavior of Seven-Membered Rings. Isoclinal Anomeric and Related Orientations1

    Article • The Journal of Organic Chemistry, January 1997, American Chemical Society (ACS)

    Professor Joaquin M Campos

  113. Selection and preliminary characterization of a Pseudomonas aeruginosa strain mineralizing selected isomers in a branchedchain dodecylbenzenesulphonate mixture

    Article • World Journal of Microbiology and Biotechnology, July 1996, Springer Science + Business Media

    Professor Joaquin M Campos

  114. 5-fluorouracil derivatives. 1. Acyclonucleosides through a tin (IV) chloride-mediated regiospecific ring opening of alkoxy-1,4-diheteroepanes

    Article • Tetrahedron, June 1996, Elsevier

    Professor Joaquin M Campos

  115. Synthesis, Molecular Modeling, and K+ Channel-Blocking Activity of Dequalinium Analogues Having Semirigid Linkers

    Article • Journal of Medicinal Chemistry, January 1996, American Chemical Society (ACS)

    Professor Joaquin M Campos

  116. (MM2) theoretical conformational analysis of seven-membered rings (IV)1: thiepane and 1,4-oxathiepane

    Article • Journal of Molecular Structure, July 1993, Elsevier

    Professor Joaquin M Campos

  117. Conformational analysis of some 1,4-dioxepane systems. 2. Methoxy-1,4-dioxepanes

    Article • The Journal of Organic Chemistry, November 1990, American Chemical Society (ACS)

    Professor Joaquin M Campos

  118. Conformational analysis of some 1,4-dioxepines by molecular mechanics (MM2)

    Article • The Journal of Organic Chemistry, December 1989, American Chemical Society (ACS)

    Professor Joaquin M Campos

  119. Carbon‐13 NMR spectra of 1,3‐dioxolanes. II—determination of α, β and γ parameters for 2‐ and 4‐methyl groups in stereoisomeric derivatives by the pattern molecule method

    Article • Magnetic Resonance in Chemistry, February 1988, Wiley

    Professor Joaquin M Campos

  120. Carbon‐13 NMR spectra of 1,3‐dioxolanes. I—new parameters for cis‐ and trans‐4‐methyl groups in 2,4‐disubstituted derivatives

    Article • Magnetic Resonance in Chemistry, September 1986, Wiley

    Professor Joaquin M Campos